POAS (Phaos Technology Holdings Cayman) PS Ratio: 20.07 (As of Jul. 26, 2026) — 89% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POAS Phaos Technology Holdings Cayman Ltd POAS
4 GF Score
Price $0.22
! 5 Warning Signs
View Full Analysis

What is Phaos Technology Holdings Cayman PS Ratio?

Phaos Technology Holdings Cayman POAS -6.08% 4 PS Ratio is 20.07 as of Jul. 26, 2026, which is 89% below its 10-year median of 190.00. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 91.04% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Phaos Technology Holdings Cayman's share price is $0.2208. Phaos Technology Holdings Cayman's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 was $0.01. Hence, Phaos Technology Holdings Cayman's PS Ratio for today is 20.07.

Good Sign:

Phaos Technology Holdings Cayman Ltd stock PS Ratio (=22.08) is close to 1-year low of 21.67.

The historical rank and industry rank for Phaos Technology Holdings Cayman's PS Ratio or its related term are showing as below:

POAS' s PS Ratio Range Over the Past 10 Years
Min: 20.07   Med: 190   Max: 602
Current: 20.07

During the past 3 years, Phaos Technology Holdings Cayman's highest PS Ratio was 602.00. The lowest was 20.07. And the median was 190.00.

POAS's PS Ratio is ranked worse than
91.04% of 804 companies
in the Medical Devices & Instruments industry
Industry Median: 2.86 vs POAS: 20.07

Phaos Technology Holdings Cayman's Revenue per Sharefor the six months ended in Oct. 2025 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 was $0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Phaos Technology Holdings Cayman was -87.50% per year.

Back to Basics: PS Ratio


Phaos Technology Holdings Cayman  (AMEX:POAS) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Phaos Technology Holdings Cayman PS Ratio Related Terms


Phaos Technology Holdings Cayman PS Ratio Historical Data

* Premium members only.

The historical data trend for Phaos Technology Holdings Cayman's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phaos Technology Holdings Cayman PS Ratio Chart

Phaos Technology Holdings Cayman Annual Data
Trend Apr23 Apr24 Apr25
PS Ratio
0.00 0.00 0.00

Phaos Technology Holdings Cayman Semi-Annual Data
Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
PS Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

POAS vs WOK, ITOC, INBS: PS Ratio Comparison

For the Medical Devices subindustry, Phaos Technology Holdings Cayman's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phaos Technology Holdings Cayman PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's PS Ratio distribution charts can be found below:

* The bar in red indicates where Phaos Technology Holdings Cayman's PS Ratio falls into.


POAS
4GF Score
Phaos Technology Holdings Cayman Ltd POAS
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phaos Technology Holdings Cayman PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Phaos Technology Holdings Cayman's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.2208/0.011
=20.07

Phaos Technology Holdings Cayman's Share Price of today is $0.2208.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Phaos Technology Holdings Cayman's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 20.07 mean?
Phaos Technology Holdings Cayman (POAS) has a PS Ratio of 20.07 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Phaos Technology Holdings Cayman and its competitors. This is 89% below median its historical median of 190.00. Over the past decade, Phaos Technology Holdings Cayman's PS Ratio has ranged from 20.07 to 602.00. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #732 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 91%.
Is Phaos Technology Holdings Cayman's PS Ratio too high?
Phaos Technology Holdings Cayman's current PS Ratio of 20.07 is 89% below median its 10-year median of 190.00. Over the past 10 years, this metric has ranged from a low of 20.07 to a high of 602.00. The Medical Devices & Instruments industry median PS Ratio is 2.86. Phaos Technology Holdings Cayman's value of 20.07 is 601.7% above this industry median. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #732 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's PS Ratio compare to WOK and ITOC?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #732 out of 804 companies for PS Ratio. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median PS Ratio is 2.86. Phaos Technology Holdings Cayman's value of 20.07 is 601.7% above this benchmark. Historically, Phaos Technology Holdings Cayman's own PS Ratio has ranged from 20.07 to 602.00 over the past decade. While the company's 10-year median is 190.00 vs. the industry median of 2.86, Phaos Technology Holdings Cayman has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phaos Technology Holdings Cayman's current PS Ratio of 20.07 is 601.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current PS Ratio is 20.07, which is 89% below median its own 10-year median of 190.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current PS Ratio of 20.07. The current PS Ratio is 20.07, which is 89% below median its 10-year median of 190.00 and 601.7% above the Medical Devices & Instruments industry median of 2.86. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current PS Ratio is 20.07 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phaos Technology Holdings Cayman Business Description

Address 83 Science Park Drive, 02-01 & 04-01A/B The Curie, Singapore Science Park 1, Singapore, SGP, 118258
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score

Get the complete analysis for POAS

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price